Corbus Pharmaceuticals Holdings (CRBP) Total Debt (2013 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Total Debt of $10.7 million for Q2 2024, down 41.4% year-over-year from $18.3 million in Q3 2023, and down 15.83% quarter-over-quarter from $12.8 million in Q1 2024.
Corbus Pharmaceuticals Holdings (CRBP) Total Debt (2013 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Total Debt history runs 6 years deep, the most recent figure standing at $10.7 million for Q2 2024.
- In Q2 2024, Total Debt fell 41.4% year-over-year to $10.7 million; the TTM figure through Jun 2024 stood at $10.7 million (down 41.4% YoY), while the FY2023 annual figure was $31.8 million, up 69.41% from the prior year.
- Total Debt for Q2 2024 stood at $10.7 million, down from $12.8 million in the prior quarter.
- The five-year high for Total Debt was $31.8 million in Q4 2023, with the low at $10.7 million in Q2 2024.
- The 5-year median for Total Debt is $18.5 million (2021), against an average of $18.5 million.
- The sharpest annual moves came in 2023 and 2024: Total Debt surged 69.41% in 2023, then sank 41.4% in 2024.
- Corbus Pharmaceuticals Holdings' Total Debt stood at $18.0 million in 2020, then advanced by 3.89% to $18.7 million in 2021, then rose by 0.27% to $18.8 million in 2022, then soared by 69.41% to $31.8 million in 2023, then sank by 66.23% to $10.7 million in 2024.
- Business Quant data shows CRBP's Total Debt at $10.7 million in Q2 2024, $12.8 million in Q1 2024, and $31.8 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 121.72 Mn | -41.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 10.74 Mn |
| Mar 31, 2024 | 12.76 Mn |
| Dec 31, 2023 | 31.82 Mn |
| Sep 30, 2023 | 17.85 Mn |
| Jun 30, 2023 | 18.34 Mn |
| Mar 31, 2023 | 18.98 Mn |
| Dec 31, 2022 | 18.78 Mn |
| Sep 30, 2022 | 19.27 Mn |
| Jun 30, 2022 | 19.09 Mn |
| Mar 31, 2022 | 18.91 Mn |
| Dec 31, 2021 | 18.73 Mn |
| Sep 30, 2021 | 18.55 Mn |
| Jun 30, 2021 | 18.37 Mn |
| Mar 31, 2021 | 18.20 Mn |
| Dec 31, 2020 | 18.03 Mn |
| Sep 30, 2020 | 17.86 Mn |
| Dec 31, 2013 | 331,243.00 |